Results 251 to 260 of about 178,774 (332)

Efficacy and survival outcomes of bevacizumab plus minocycline for glioblastoma. [PDF]

Am J Transl Res
Tong Y, Rao H, Li Y, Chang C, Yang Y.
europepmc   +1 more source

Efficacy of the combined use of bevacizumab and irinotecan in a human colorectal cancer xenograft model analysed by SPECT imaging [PDF]

, 2011
Geboes, Karen, Laurent, Stéphanie, Peeters, Marc, Van Damme, Nancy, Van De Wiele, Christophe, VANGESTEL, CHRISTEL   +5 more
core   +1 more source

Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer

Clinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 403-413, February 2026.
Circulating tumor cells (CTCs) and tumor‐derived extracellular vesicles (tdEVs) are promising biomarkers for predicting survival and informing treatment decisions in metastatic colorectal cancer (mCRC); yet their clinical application remains limited. In this study, we analyzed CellSearch image archives from 446 patients with mCRC treated in the CAIRO2 ...
Maddalena Centanni, Afroditi Nanou, Leon W. M. M. Terstappen, Kees J. A. Punt, Frank A.W. Coumans, Mats O. Karlsson, Lena E. Friberg   +6 more
wiley   +1 more source

Treatment results switching from aflibercept to bevacizumab in wet age-related macular degeneration. [PDF]

Int J Ophthalmol
Kananen F.
europepmc   +1 more source

Integrative Single‐Cell Analysis Reveals Targetable Vacuole Membrane Protein 1‐Mediated Mechanism of Tumor Angiogenesis in Glioblastoma

MedComm, Volume 7, Issue 2, February 2026.
VMP1 promotes angiogenesis in glioblastoma (GBM) through VEGFA‐VEGFR2 signaling and activation of endothelial cells. The FDA‐approved anti‐VEGFA antibody, bevacizumab (BEV), can counteract VMP1's tumor‐promoting effect in GBM. Targeting VMP1 or its associated pathways could be a new therapeutic strategy, either alone or in combination with BEV.
Lei Jin, Bo Chen, Junbo Liao, Wenlong Guo, Zhiyuan Zhu, Salida Ali, Gilberto Ka‐Kit Leung, Peng Wang, Karrie M. Kiang   +8 more
wiley   +1 more source

Bevacizumab-Associated Bowel Perforation Causing Evisceration. [PDF]

Cureus
Fazel Darbandi M, Johnson G, Hardy K, Vergis A.   +3 more
europepmc   +1 more source

Tetravalent antibodies are more potent and efficacious erythropoiesis‐stimulating agents than erythropoietin in vivo

Protein Science, Volume 35, Issue 2, February 2026.
Abstract Recent studies have shown that tetravalent antibodies are potent and efficacious agonists of the erythropoietin (EPO) receptor (EPOR) both in vitro and in vivo. To identify antibody‐based erythropoiesis‐stimulating agents (ESAs) with therapeutic potential, we evaluated various tetravalent antibody formats for EPOR agonism and key biophysical ...
Jarrett J. Adams, Levi L. Blazer, Jacky Chung, Minoo Karimi, Taylor Davidson, Bailey Blair, Carlos Waddle, Craig A. Hokanson, Heather A. Bruce, Alexander U. Singer, Eva‐Maria Tombak, Kiira Gildemann, Nele Tamberg, Kaja Kiiver, Mart Ustav Jr, Yue Ma, Luigi Colombo, Lily Jun‐Shen Huang, Stephen W. Michnick, Orson W. Moe, Sachdev S. Sidhu   +20 more
wiley   +1 more source

Pathological changes and aquaporin-4 expression after bevacizumab treatment of traumatic penumbra in the rat brain. [PDF]

Sci Rep
Lin XY, Usman M, Huang DX, Lu H.
europepmc   +1 more source

Efficacy of Subconjunctival Injection of Bevacizumab in Regressing Corneal Neovascularisation

, 2019
Syed Muhammad Ali Shah
openalex   +1 more source